Back to search
FDAFDA · Food and drugs·Recall number D-1442-2012

Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30

Published August 15, 2012 · Recall initiated: May 18, 2012

Summary

FDA records drug Class II recall D-1442-2012, published August 15, 2012 and initiated May 18, 2012. Recalling firm: Teva Pharmaceuticals USA, Inc.; Status: Terminated; Reported quantity: 6,647 cartons; Lot: Lot number X05011, Exp 08/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.

What to do

Voluntary: Firm initiated · Letter

Get an email if COPAXONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
COPAXONE
Manufacturer
Teva Pharmaceuticals USA, Inc.
Distributor
Nationwide
Lot
Lot number X05011, Exp 08/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30 recalled?

Yes. FDA published recall D-1442-2012 on August 15, 2012. Reported hazard: Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: COPAXONE.